Alembic Pharmaceuticals

quarterly
yearly
ParticularsJun '23Sep '23Dec '23Mar '24Jun '24
Revenue1,3441,4881,5921,4821,479
Expenses1,2471,3541,3351,2661,266
EBITDA177.57216.41340.44295.41294.57
EBIT111.82149.23271.36226.29225.89
Profit Before Tax97.53133.84256.70216.16213.20
Net Profit97.53133.84233.24201.87176.19
Financial Ratios
Operating Profit Margin13.33%14.63%21.43%20.03%19.96%
Net Profit Margin7.32%9.05%14.68%13.69%11.94%
Earning Per Share (Diluted)4.966.8111.8710.278.96
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.3.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ